Dashboard
Manage Tickers

BIORBIORA THERAPEUTICS, INC.

Nasdaq bioratherapeutics.com


$ 0.70 $ 0.01 (1.14 %)    

Monday, 26-Aug-2024 13:58:00 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.46 $ -4.66 (-0.97 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.34 (-0.24 %)
TLT $ 98.13 $ -0.25 (-0.25 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 0.6857
$ 0.68
$ 0.65 x 300
-- x --
$ 0.68 - $ 0.70
$ 0.48 - $ 3.38
97,361
na
25.01M
$ 1.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-28-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-18-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-biora-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Bior...
08/13/2024 18:04:10

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $15 pr...

biora-therapeutics-q2-2024-gaap-eps-004-beats-045-estimate-sales-318000k-up-from-2000k-yoy
Biora Therapeutics Q2 2024 GAAP EPS $(0.04...
08/12/2024 20:38:13

Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(...

biora-therapeutics-inks-financing-agreements-with-its-existing-convertible-notes-holders
Biora Therapeutics Inks Financing Agreemen...
08/12/2024 20:09:28

hc-wainwright--co-reiterates-buy-on-biora-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Bior...
07/22/2024 10:41:20

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $15 pr...

biora-therapeutics-announces-presentation-of-supplemental-data-from-phase-1-bt-600-trial-says-pharmacokinetic-and-tissue-data-confirm-navicap-platform-delivers-topically-through-the-entire-colon-with-lower-systemic-concentrations-as-desired
Biora Therapeutics Announces Presentation ...
07/18/2024 12:01:57

biora-therapeutics-announces-clinical-trial-results-for-bt-600
Biora Therapeutics Announces Clinical Tria...
07/01/2024 12:01:49

Drug-device combination leverages Biora's NaviCap™ platform to deliver tofacitinib directly to colonic tissue as a potentia...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/17/2024 20:31:09

biora-therapeutics-says-company-did-not-regain-compliance-with-nasdaqs-mvls-rule-by-june-10-2024
Biora Therapeutics Says Company Did Not Re...
06/14/2024 20:35:26

-SEC Filing

biora-therapeutics-says-notified-co-that-its-securities-were-subject-to-delisting-from-nasdaq-unless-company-timely-requests-hearing-before-panel
Biora Therapeutics Says Notified Co That I...
06/14/2024 20:34:36

-SEC Filing-SEC Filing

biora-therapeutics-to-present-on-the-biojet-systemic-oral-delivery-platform-at-the-next-gen-peptide-formulation--delivery-summit-2024
Biora Therapeutics To Present On The BioJe...
06/11/2024 12:06:33

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it w...

why-netease-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session
Why NetEase Shares Are Trading Lower? Here...
05/24/2024 17:57:35

why-ross-stores-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket
Why Ross Stores Shares Are Trading Higher ...
05/24/2024 12:22:48

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
05/24/2024 12:07:16

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 20:31:02

biora-therapeutics-to-present-clinical-data-on-device-function-of-the-navicap-platform-at-digestive-disease-week-2024
Biora Therapeutics To Present Clinical Dat...
05/20/2024 12:15:49

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, presented a poster titled...

hc-wainwright--co-reiterates-buy-on-biora-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Bior...
05/16/2024 15:49:23

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $15 pr...

biora-therapeutics-q1-2024-gaap-eps-014-beats-045-estimate-sales-542000k
Biora Therapeutics Q1 2024 GAAP EPS $(0.14...
05/15/2024 20:09:49

Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(...

biora-therapeutics-to-present-clinical-data-on-device-function-of-the-navicap-oral-delivery-platform-at-digestive-disease-week-2024
Biora Therapeutics To Present Clinical Dat...
05/06/2024 12:18:46

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it w...

biora-therapeutics-announces-completion-of-multiple-ascending-dose-cohorts-for-clinical-trial-of-bt-600
Biora Therapeutics Announces Completion Of...
04/30/2024 12:07:12

Dosing of all patients in the trial has been successfully completed Final results are expected to be available in late Q2 2024S...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION